Nu blir en koncern två separata bolag. GASPOROX delar ut aktierna i GPX Medical i samband med att GPX Medical är på väg mot börsen.

GASPOROX vd och GPX Medicals styrelseordförande, Märta Lewander Xu berättar tillsammans med GPX Medicals vd, Hanna Sjöström, om denna förändring.

För dig som är aktieägare i GASPOROX finns mer att läsa mer här: Informationsbroschyr utdelning

One corporation now becomes two separate companies. GASPOROX distributes its shares in GPX Medical in connection with GPX Medical being listed on the stock exchange.

GASPOROX CEO and GPX Medical’s Chairman, Märta Lewander Xu, is talking this change through, together with GPX Medical’s CEO, Hanna Sjöström.

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hanna.sjostrom@gpxmedical.se

Contact

GPX Medical AB (publ)
Tellusgatan 13
224 57 Lund
Sweden
info@gpxmedical.se

Organization number: 559069-9012